Tandem Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.93M | Sell |
7,531
-17
| -0.2% | -$6.61K | 1.48% | 23 |
|
|
2025
Q1 | $3.28M | Sell |
7,548
-115
| -2% | -$50K | 1.83% | 18 |
|
|
2024
Q4 | $2.83M | Sell |
7,663
-18
| -0.2% | -$6.64K | 1.51% | 21 |
|
|
2024
Q3 | $3.99M | Sell |
7,681
-230
| -3% | -$120K | 2.1% | 13 |
|
|
2024
Q2 | $4.2M | Sell |
7,911
-135
| -2% | -$71.6K | 2.3% | 11 |
|
|
2024
Q1 | $4.17M | Sell |
8,046
-92
| -1% | -$47.7K | 2.37% | 9 |
|
|
2023
Q4 | $3.84M | Sell |
8,138
-376
| -4% | -$177K | 2.38% | 7 |
|
|
2023
Q3 | $3.71M | Sell |
8,514
-538
| -6% | -$234K | 2.55% | 8 |
|
|
2023
Q2 | $4.02M | Buy |
9,052
+3
| +0% | +$1.33K | 2.62% | 7 |
|
|
2023
Q1 | $4.16M | Buy |
9,049
+55
| +0.6% | +$25.3K | 2.93% | 7 |
|
|
2022
Q4 | $4.61M | Sell |
8,994
-79
| -0.9% | -$40.5K | 3.64% | 3 |
|
|
2022
Q3 | $4.64M | Sell |
9,073
-2
| -0% | -$1.02K | 3.91% | 3 |
|
|
2022
Q2 | $4.38M | Hold |
9,075
| – | – | 3.51% | 4 |
|
|
2022
Q1 | $4.56M | Hold |
9,075
| – | – | 3.16% | 6 |
|
|
2021
Q4 | $4.21M | Buy |
9,075
+35
| +0.4% | +$16.2K | 2.43% | 13 |
|
|
2021
Q3 | $3.37M | Buy |
9,040
+58
| +0.6% | +$21.6K | 2.12% | 17 |
|
|
2021
Q2 | $3.43M | Buy |
8,982
+22
| +0.2% | +$8.4K | 2.16% | 17 |
|
|
2021
Q1 | $3.22M | Buy |
8,960
+46
| +0.5% | +$16.5K | 2.22% | 17 |
|
|
2020
Q4 | $2.86M | Hold |
8,914
| – | – | 2.15% | 18 |
|
|
2020
Q3 | $2.39M | Buy |
8,914
+50
| +0.6% | +$13.4K | 2.11% | 16 |
|
|
2020
Q2 | $2.33M | Sell |
8,864
-944
| -10% | -$248K | 2.28% | 14 |
|
|
2020
Q1 | $2.23M | Buy |
9,808
+160
| +2% | +$36.3K | 2.51% | 10 |
|
|
2019
Q4 | $2.91M | Buy |
+9,648
| New | +$2.91M | 2.5% | 10 |
|